Bariatric Surgery
Conditions
Keywords
bariatric surgery, follow-up, weight loss, complications, comorbidities evolution
Brief summary
The aim of this cohort study is to collect prospectively clinical data on all the patients admitted in the investigators department for bariatric surgery or for any complication of a bariatric procedure. The investigators goal is not only to improve the follow-up but also to assess and publish the investigators results regarding weight loss and the complication rate.
Interventions
PROCEDUREbariatric surgery
gastric bypass Or gastric banding Or Biliopancreatic diversion with duodenal switch Or sleeve gastrectomy Or endoscopic procedure (Endobarrier,…)
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* History of bariatric surgery procedure
Exclusion criteria
* Patients \< 16 years * Patients \> 80 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight loss in kg | Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up) |
| Weight loss in kg/m² | Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up) |
| Excess Weight Loss | Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up) |
| % weight loss | Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| surgical complications | per and postoperative (up to 25 years or loss to follow-up) | leaks, hemorrhage, phlebitis, pulmonary embolism, nutritional deficiencies, occlusions,… |
| type of surgical procedure | at the time of surgery (Day 1) | gastric bypass, sleeve gastrectomy, gastric banding, biliopancreatic diversion, redo surgery, endoscopic procedure… |
| number of oral medications | after surgery (up to 25 years or loss to follow-up) | evolution of comorbidities: evolution of medical treatment |
| dose of insulin | after surgery (up to 25 years or loss to follow-up) | evolution of comorbidities: evolution of medical treatment |
| age | before surgery (Day 0) | demographic data: age |
| gender | before surgery (Day 0) | demographic data: gender |
| Type of comorbidities | before surgery (Day 0) | demographic data: comorbidities (diabetes, arterial hypertension, sleep apnea, dyslipidemia) |
Countries
France
Contacts
Primary ContactMaud ROBERT, Pr
Outcome results
None listed